Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceleromyographic Assessment of Neuromuscular Blockade: TOF-Watch-SX Versus TOFscan

NCT02433769 is registered in ClinicalTrials.gov with Endeavor Health as lead sponsor.

NCT NCT02433769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02433769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceleromyographic Assessment of Neuromuscular Blockade: TOF-Watch-SX Versus TOFscan
Lead sponsor
Endeavor Health
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2015
Completion date
May 31, 2017
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade